dementia

brain pills alzheimers drug reaction down syndrome
Biotech

Cognition's phase 2 SHIMMER results allow dementia drug to shine

The phase 2 study in dementia with Lewy bodies met its primary endpoint of safety and tolerability, Cognition said.
James Waldron Dec 18, 2024 7:00am
Alzheimers dementia brain memory loss

CervoMed's ex-Vertex drug fails to reduce dementia symptoms

Dec 10, 2024 8:20am
Graphic of a brain inside of a lightbulb

Trace uses $101M series A to go after same ALS target as Lilly

Nov 12, 2024 7:00am
Graphic of two hands shaking under a red and purple light

Astellas pays $50M for option on AviadoBio dementia gene therapy

Oct 8, 2024 7:40am
Photo of a final puzzle piece about to fit into a puzzle

Lilly pays QurAlis $45M for preclinical ALS, dementia prospect

Jun 3, 2024 5:00am
Black and white graphic image of the brain

Gene inhibition prevents types of brain damage in mice, cells

Apr 8, 2024 7:20am